Rapid Micro Biosystems (RPID) Stock Forecast, Price Target & Predictions
RPID Stock Forecast
Rapid Micro Biosystems stock forecast is as follows: an average price target of $8.00 (represents a 788.89% upside from RPID’s last price of $0.90) and a rating consensus of 'Hold', based on 1 wall street analysts offering a 1-year stock forecast.
RPID Price Target
The average price target for Rapid Micro Biosystems (RPID) is $8.00 based on 1-year price targets from 1 Wall Street analysts in the past 3 months, with a price target range of $8.00 to $8.00. This represents a potential 788.89% upside from RPID's last price of $0.90.
RPID Analyst Ratings
According to 1 Wall Street analysts, Rapid Micro Biosystems's rating consensus is 'Hold'. The analyst rating breakdown for RPID stock is 0 'Strong Buy' (0.00%), 0 'Buy' (0.00%), 1 'Hold' (100.00%), 0 'Sell' (0.00%), and 0 'Strong Sell' (0.00%).
Rapid Micro Biosystems Price Target by Analyst
| Date | Analyst | Company | Price Target | Price when Published | Price Target/Price when Published | Price Target/Last Closing Price |
|---|---|---|---|---|---|---|
| May 11, 2022 | Morgan Stanley | $8.00 | $4.11 | 94.65% | 788.89% |
The latest Rapid Micro Biosystems stock forecast, released on May 11, 2022 by Morgan Stanley company, set a price target of $8.00, which represents a 94.65% increase from the stock price at the time of the forecast ($4.11), and a 788.89% increase from RPID last price ($0.90).
Rapid Micro Biosystems Price Target by Period
| 1M | 3M | 12M | |
|---|---|---|---|
| # Anlaysts | - | - | - |
| Avg Price Target | - | - | - |
| Last Closing Price | $0.90 | $0.90 | $0.90 |
| Upside/Downside | -100.00% | -100.00% | -100.00% |
In the current month, the average price target of Rapid Micro Biosystems stock is -, according to 0 Wall Street analyst offering twelve months forecast. The average price target represents a -100.00% decrease as opposed to Rapid Micro Biosystems's last price of $0.90. This month's average price target is down NaN% compared to last quarter, and down NaN% compared to last year.
Analyst Ratings Upgrades/Downgrades
| Date | Company | Previous Rating | New Rating | Rating Change |
|---|---|---|---|---|
| May 11, 2022 | Morgan Stanley | Equal-Weight | Equal-Weight | Hold |
Rapid Micro Biosystems's last stock rating was published by Morgan Stanley on May 11, 2022. The company gave RPID a "Equal-Weight" rating, the same as its previous rate.
Rapid Micro Biosystems Financial Forecast
Rapid Micro Biosystems Revenue Forecast
| Dec 25 | Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Jun 22 | Mar 22 | Dec 21 | Sep 21 | Jun 21 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | - | - | - | - | - | - | - | - | $6.34M | $6.14M | $5.00M | $5.04M | $4.37M | $4.74M | $3.86M | $4.16M | $5.21M | $6.90M | $6.13M |
| Avg Forecast | $9.20M | $8.10M | $7.40M | $6.70M | $7.60M | $6.55M | $6.00M | $5.50M | $6.15M | $5.55M | $4.15M | $4.13M | $4.50M | $3.97M | $4.35M | $5.16M | $5.87M | $6.57M | $5.93M |
| High Forecast | $9.52M | $8.38M | $7.66M | $6.93M | $7.87M | $6.78M | $6.21M | $5.69M | $6.23M | $5.74M | $4.30M | $4.28M | $4.66M | $3.97M | $4.35M | $5.16M | $5.87M | $6.57M | $5.93M |
| Low Forecast | $8.88M | $7.82M | $7.14M | $6.47M | $7.33M | $6.32M | $5.79M | $5.31M | $6.07M | $5.36M | $4.00M | $3.99M | $4.34M | $3.97M | $4.35M | $5.16M | $5.87M | $6.57M | $5.93M |
| # Analysts | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 2 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 |
| Surprise % | - | - | - | - | - | - | - | - | 1.03% | 1.11% | 1.21% | 1.22% | 0.97% | 1.19% | 0.89% | 0.81% | 0.89% | 1.05% | 1.03% |
Rapid Micro Biosystems's average Quarter revenue forecast for Mar 24 based on 1 analysts is $5.50M, with a low forecast of $5.31M, and a high forecast of $5.69M. RPID's average Quarter revenue forecast represents a -13.21% decrease compared to the company's last Quarter revenue of $6.34M (Dec 23).
Rapid Micro Biosystems EBITDA Forecast
| Dec 25 | Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Jun 22 | Mar 22 | Dec 21 | Sep 21 | Jun 21 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| # Analysts | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 2 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 |
| EBITDA | - | - | - | - | - | - | - | - | $-12.48M | $-14.45M | $-15.05M | $-14.87M | $-17.26M | $-16.15M | $-13.69M | $-14.34M | $-14.14M | $-25.36M | $-10.54M |
| Avg Forecast | $-9.20M | $-8.10M | $-7.40M | $-6.70M | $-7.60M | $-6.55M | $-6.00M | $-5.50M | $-6.15M | $-5.55M | $-4.15M | $-4.13M | $-4.50M | $-3.97M | $-4.35M | $-13.47M | $-5.87M | $-6.57M | $-443.86M |
| High Forecast | $-8.88M | $-7.82M | $-7.14M | $-6.47M | $-7.33M | $-6.32M | $-5.79M | $-5.31M | $-6.07M | $-5.36M | $-4.00M | $-3.99M | $-4.34M | $-3.97M | $-4.35M | $-10.77M | $-5.87M | $-6.57M | $-355.09M |
| Low Forecast | $-9.52M | $-8.38M | $-7.66M | $-6.93M | $-7.87M | $-6.78M | $-6.21M | $-5.69M | $-6.23M | $-5.74M | $-4.30M | $-4.28M | $-4.66M | $-3.97M | $-4.35M | $-16.16M | $-5.87M | $-6.57M | $-532.64M |
| Surprise % | - | - | - | - | - | - | - | - | 2.03% | 2.60% | 3.63% | 3.60% | 3.84% | 4.07% | 3.15% | 1.06% | 2.41% | 3.86% | 0.02% |
undefined analysts predict RPID's average Quarter EBITDA for undefined to be $NaN, with a high of $NaN and a low of $NaN. This is NaN% lower than Rapid Micro Biosystems's previous annual EBITDA (undefined) of $NaN.
Rapid Micro Biosystems Net Income Forecast
| Dec 25 | Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Jun 22 | Mar 22 | Dec 21 | Sep 21 | Jun 21 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| # Analysts | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 2 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 |
| Net Income | - | - | - | - | - | - | - | - | $-11.17M | $-13.39M | $-14.02M | $-13.89M | $-16.45M | $-16.34M | $-13.09M | $-14.93M | $-14.61M | $-24.99M | $-11.83M |
| Avg Forecast | $-10.04M | $-9.61M | $-9.17M | $-9.17M | $-9.83M | $-11.14M | $-12.08M | $-12.66M | $-12.59M | $-13.39M | $-14.85M | $-15.94M | $-15.72M | $-15.99M | $-13.85M | $-14.03M | $-12.21M | $-16.90M | $-498.37M |
| High Forecast | $-9.59M | $-9.17M | $-8.75M | $-8.75M | $-9.38M | $-10.63M | $-11.53M | $-12.09M | $-12.50M | $-12.78M | $-14.17M | $-15.21M | $-15.01M | $-15.99M | $-13.85M | $-11.22M | $-12.21M | $-16.90M | $-398.70M |
| Low Forecast | $-10.50M | $-10.04M | $-9.59M | $-9.59M | $-10.27M | $-11.64M | $-12.63M | $-13.24M | $-12.68M | $-14.00M | $-15.52M | $-16.66M | $-16.44M | $-15.99M | $-13.85M | $-16.83M | $-12.21M | $-16.90M | $-598.05M |
| Surprise % | - | - | - | - | - | - | - | - | 0.89% | 1.00% | 0.94% | 0.87% | 1.05% | 1.02% | 0.95% | 1.06% | 1.20% | 1.48% | 0.02% |
Rapid Micro Biosystems's average Quarter net income forecast for undefined is $NaN, with a range of $NaN to $NaN. RPID's average Quarter net income forecast represents a NaN% decrease compared to the company's last Quarter net income of $NaN (undefined).
Rapid Micro Biosystems SG&A Forecast
| Dec 25 | Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Jun 22 | Mar 22 | Dec 21 | Sep 21 | Jun 21 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| # Analysts | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 2 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 |
| SG&A | - | - | - | - | - | - | - | - | $8.70M | $9.70M | $9.93M | $9.93M | $11.26M | $11.12M | $9.89M | $9.55M | $9.12M | $8.37M | $6.75M |
| Avg Forecast | $13.24M | $11.66M | $10.65M | $9.64M | $10.94M | $9.43M | $8.63M | $7.91M | $8.85M | $7.99M | $5.97M | $5.95M | $6.48M | $5.71M | $6.26M | $7.43M | $8.44M | $9.45M | $8.54M |
| High Forecast | $13.70M | $12.06M | $11.02M | $9.98M | $11.32M | $9.76M | $8.94M | $8.19M | $8.97M | $8.27M | $6.18M | $6.16M | $6.70M | $5.71M | $6.26M | $7.43M | $8.44M | $9.45M | $8.54M |
| Low Forecast | $12.78M | $11.25M | $10.28M | $9.30M | $10.55M | $9.10M | $8.33M | $7.64M | $8.73M | $7.71M | $5.76M | $5.74M | $6.25M | $5.71M | $6.26M | $7.43M | $8.44M | $9.45M | $8.54M |
| Surprise % | - | - | - | - | - | - | - | - | 0.98% | 1.21% | 1.66% | 1.67% | 1.74% | 1.95% | 1.58% | 1.29% | 1.08% | 0.89% | 0.79% |
Rapid Micro Biosystems's average Quarter SG&A projection for Mar 24 is $7.91M, based on 1 Wall Street analysts, with a range of $7.64M to $8.19M. The forecast indicates a -9.01% fall compared to RPID last annual SG&A of $8.70M (Dec 23).
Rapid Micro Biosystems EPS Forecast
| Dec 25 | Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Jun 22 | Mar 22 | Dec 21 | Sep 21 | Jun 21 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| # Analysts | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 2 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 |
| EPS | - | - | - | - | - | - | - | - | $-0.00 | $-0.31 | $-0.33 | $-0.32 | $-0.39 | $-0.38 | $-0.31 | $-0.35 | $-0.35 | $-0.71 | $-0.31 |
| Avg Forecast | $-0.23 | $-0.22 | $-0.21 | $-0.21 | $-0.23 | $-0.26 | $-0.28 | $-0.29 | $-0.29 | $-0.31 | $-0.34 | $-0.36 | $-0.36 | $-0.37 | $-0.32 | $-0.34 | $-0.28 | $-0.39 | $-1.09 |
| High Forecast | $-0.22 | $-0.21 | $-0.20 | $-0.20 | $-0.21 | $-0.24 | $-0.26 | $-0.28 | $-0.29 | $-0.29 | $-0.32 | $-0.35 | $-0.34 | $-0.37 | $-0.32 | $-0.34 | $-0.28 | $-0.39 | $-1.09 |
| Low Forecast | $-0.24 | $-0.23 | $-0.22 | $-0.22 | $-0.24 | $-0.27 | $-0.29 | $-0.30 | $-0.29 | $-0.32 | $-0.36 | $-0.38 | $-0.38 | $-0.37 | $-0.32 | $-0.34 | $-0.28 | $-0.39 | $-1.09 |
| Surprise % | - | - | - | - | - | - | - | - | 0.00% | 1.01% | 0.97% | 0.88% | 1.08% | 1.04% | 0.98% | 1.04% | 1.25% | 1.83% | 0.28% |
According to undefined Wall Street analysts, Rapid Micro Biosystems's projected average Quarter EPS for undefined is $NaN, with a low estimate of $NaN and a high estimate of $NaN. This represents a NaN% decrease compared to RPID previous annual EPS of $NaN (undefined).
Rapid Micro Biosystems Peer Comparison by Price Target
| Ticker | Company | Last Closing Price | Avg Price Target | Upside/Downside | Avg Rating |
|---|---|---|---|---|---|
| OWLT | Owlet | $4.69 | $196.00 | 4079.10% | Buy |
| RPID | Rapid Micro Biosystems | $1.06 | $8.00 | 654.72% | Hold |
| BJDX | Bluejay Diagnostics | $4.38 | $10.00 | 128.31% | Buy |
| LUNG | Pulmonx | $6.13 | $13.00 | 112.07% | Buy |
| RXST | RxSight | $38.04 | $70.14 | 84.38% | Buy |
| KIDS | OrthoPediatrics | $22.46 | $39.50 | 75.87% | Buy |
| LIVN | LivaNova | $49.94 | $68.25 | 36.66% | Buy |
| OFIX | Orthofix Medical | $17.93 | $24.00 | 33.85% | |
| BVS | Bioventus | $11.15 | $12.00 | 7.62% | Buy |
| SRDX | Surmodics | $39.96 | $39.50 | -1.15% | Buy |